Last updated on May 2019

A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"

Brief description of study

A Randomized, Double-blind, Parallel-group, Three-arm, Placebo-controlled, Multi-Site Therapeutic Equivalence Study with Clinical End-points Comparing Test Product "Oxymetazoline hydrochloride Cream, 1%" to Reference Product "RHOFADE Cream, 1%" in the Treatment of Moderate to Severe Persistent Facial Erythema of Rosacea

Clinical Study Identifier: NCT03954444

Find a site near you

Start Over

Site 1

Lynchburg, VA United States
  Connect »